BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19002102)

  • 1. Cultured CD4T cells and primary human lymphocytes express hOATPs: intracellular accumulation of saquinavir and lopinavir.
    Janneh O; Hartkoorn RC; Jones E; Owen A; Ward SA; Davey R; Back DJ; Khoo SH
    Br J Pharmacol; 2008 Nov; 155(6):875-83. PubMed ID: 19002102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P-glycoprotein, multidrug resistance-associated proteins and human organic anion transporting polypeptide influence the intracellular accumulation of atazanavir.
    Janneh O; Anwar T; Jungbauer C; Kopp S; Khoo SH; Back DJ; Chiba P
    Antivir Ther; 2009; 14(7):965-74. PubMed ID: 19918100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of P-glycoprotein and multidrug resistance-associated proteins modulates the intracellular concentration of lopinavir in cultured CD4 T cells and primary human lymphocytes.
    Janneh O; Jones E; Chandler B; Owen A; Khoo SH
    J Antimicrob Chemother; 2007 Nov; 60(5):987-93. PubMed ID: 17890284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular accumulation of efavirenz and nevirapine is independent of P-glycoprotein activity in cultured CD4 T cells and primary human lymphocytes.
    Janneh O; Chandler B; Hartkoorn R; Kwan WS; Jenkinson C; Evans S; Back DJ; Owen A; Khoo SH
    J Antimicrob Chemother; 2009 Nov; 64(5):1002-7. PubMed ID: 19748977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentration-dependent effects and intracellular accumulation of HIV protease inhibitors in cultured CD4 T cells and primary human lymphocytes.
    Janneh O; Bray PG; Jones E; Wyen C; Chiba P; Back DJ; Khoo SH
    J Antimicrob Chemother; 2010 May; 65(5):906-16. PubMed ID: 20237075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-Glycoprotein and transporter MRP1 reduce HIV protease inhibitor uptake in CD4 cells: potential for accelerated viral drug resistance?
    Jones K; Bray PG; Khoo SH; Davey RA; Meaden ER; Ward SA; Back DJ
    AIDS; 2001 Jul; 15(11):1353-8. PubMed ID: 11504956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efflux of saquinavir, ritonavir and lopinavir from primary human cells.
    Diker B; Janneh O; van Heeswijk RP; Copeland KF
    Drug Metab Lett; 2010 Dec; 4(4):241-5. PubMed ID: 20690898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Montelukast is a potent and durable inhibitor of multidrug resistance protein 2-mediated efflux of taxol and saquinavir.
    Roy U; Chakravarty G; Honer Zu Bentrup K; Mondal D
    Biol Pharm Bull; 2009 Dec; 32(12):2002-9. PubMed ID: 19952419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of protease inhibitor-containing regimens on lymphocyte multidrug resistance transporter expression.
    Ford J; Meaden ER; Hoggard PG; Dalton M; Newton P; Williams I; Khoo SH; Back DJ
    J Antimicrob Chemother; 2003 Sep; 52(3):354-8. PubMed ID: 12917239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human organic anion-transporting polypeptide OATP-A (SLC21A3) acts in concert with P-glycoprotein and multidrug resistance protein 2 in the vectorial transport of Saquinavir in Hep G2 cells.
    Su Y; Zhang X; Sinko PJ
    Mol Pharm; 2004 Jan; 1(1):49-56. PubMed ID: 15832500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRP (ABCC) transporters-mediated efflux of anti-HIV drugs, saquinavir and zidovudine, from human endothelial cells.
    Eilers M; Roy U; Mondal D
    Exp Biol Med (Maywood); 2008 Sep; 233(9):1149-60. PubMed ID: 18535159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the intracellular accumulation of saquinavir in peripheral blood mononuclear cells by inhibitors of MRP1, MRP2, P-gp and BCRP.
    Janneh O; Owen A; Chandler B; Hartkoorn RC; Hart CA; Bray PG; Ward SA; Back DJ; Khoo SH
    AIDS; 2005 Dec; 19(18):2097-102. PubMed ID: 16284458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of grapefruit juice and orange juice components on P-glycoprotein- and MRP2-mediated drug efflux.
    Honda Y; Ushigome F; Koyabu N; Morimoto S; Shoyama Y; Uchiumi T; Kuwano M; Ohtani H; Sawada Y
    Br J Pharmacol; 2004 Dec; 143(7):856-64. PubMed ID: 15504753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The accumulation and metabolism of zidovudine in 3T3-F442A pre-adipocytes.
    Janneh O; Owen A; Bray PG; Back DJ; Pirmohamed M
    Br J Pharmacol; 2010 Jan; 159(2):484-93. PubMed ID: 20015290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the intracellular accumulation of HIV protease inhibitors in vitro and the effect of active transport.
    Jones K; Hoggard PG; Sales SD; Khoo S; Davey R; Back DJ
    AIDS; 2001 Apr; 15(6):675-81. PubMed ID: 11371681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of anti-HIV protease inhibitors with the multidrug transporter P-glycoprotein (P-gp) in human cultured cells.
    Washington CB; Duran GE; Man MC; Sikic BI; Blaschke TF
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Nov; 19(3):203-9. PubMed ID: 9803961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P-glycoprotein expression affects the intracellular concentration and antiviral activity of the protease inhibitor saquinavir in a T cell line.
    Maffeo A; Bellomi F; Solimeo I; Bambacioni F; Scagnolari C; De Pisa F; Dupuis ML; Cianfriglia M; Antonelli G; Turriziani O
    New Microbiol; 2004 Apr; 27(2 Suppl 1):119-26. PubMed ID: 15646074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of P-glycoprotein in the efflux of raltegravir from human intestinal cells and CD4+ T-cells as an interaction target for anti-HIV agents.
    Hashiguchi Y; Hamada A; Shinohara T; Tsuchiya K; Jono H; Saito H
    Biochem Biophys Res Commun; 2013 Sep; 439(2):221-7. PubMed ID: 23981805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P-glycoprotein and mutlidrug resistance-associated proteins limit the brain uptake of saquinavir in mice.
    Park S; Sinko PJ
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1249-56. PubMed ID: 15528451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both P-gp and MRP2 mediate transport of Lopinavir, a protease inhibitor.
    Agarwal S; Pal D; Mitra AK
    Int J Pharm; 2007 Jul; 339(1-2):139-47. PubMed ID: 17451894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.